DJIA52002.41 -175.28
S&P 5007659.44 -84.62
NASDAQ26140.03 -572.99
Russell 20002721.37 -45.90
German DAX25622.61 239.99
FTSE 10010881.90 41.55
CAC 407956.70 22.00
EuroStoxx 506203.55 32.40
Nikkei 22565324.29 898.34
Hang Seng24186.83 124.11
Shanghai Comp3716.28 8.80
KOSPI5668.05 113.83
Bloomberg Comm IDX144.42 0.53
WTI Crude-fut109.69 4.08
Brent Crude-fut101.84 4.31
Natural Gas3.12 -0.09
Gasoline-fut3.24 0.10
Gold-fut4186.70 -5.60
Silver-fut57.13 -0.47
Platinum-fut1639.70 4.10
Palladium-fut1115.00 -16.50
Copper-fut6.56 0.00
Aluminum-spot3195.00 0.00
Coffee-fut305.55 6.85
Soybeans-fut1260.50 -3.75
Wheat-fut659.75 -9.50
Bitcoin81677.46 -813.88
Ethereum USD2421.45 -38.86
Litecoin59.56 -1.23
Dogecoin0.08 0.00
EUR/USD1.1198 0.0070
USD/JPY158.27 -0.60
GBP/USD1.3255 0.0107
USD/CHF0.8296 -0.0085
USD IDX101.78 -0.23
US 10-Yr TR5.079 -0.008
GER 10-Yr TR3.4206 0.0114
JAP 10-Yr TR2.937 0.001
Fed Funds4 0
SOFR3.89 0.01
High-rise commercial buildings

Sub Markets

Topics

Alternative Assets  + Direct Investment  + M&As  + Real Assets  | 
Water Tech Company Xylem to Buy Evoqua in $7.5B Deal

Water Tech Company Xylem to Buy Evoqua in $7.5B Deal

Wahington, DC-based global water technology company Xylem (XYL) to acquire Pittsburgh, PA-based water treatment solutions and services provider Evoqua (AQUA) in an all-stock transaction with an enterprise value of approximately $7.5bn.

In an all-stock transaction, AQUA shareholders will receive 0.48 shares of XYL for each AQUA share, representing a value of $52.89 per share or a 29% premium based on Xylem and Evoqua closing prices as of January 20, 2023.

Xylem expects the acquisition to deliver $140 million in cost synergies within three years. The transaction is anticipated to close in the middle of the year.

“Solving the world’s water challenges has never been more urgent. Our acquisition of Evoqua creates a transformative global platform to address water scarcity, affordability and resilience at even greater scale,” said Patrick Decker, President and CEO of Xylem.

Upon closing, Xylem shareholders will own approximately 75% and Evoqua shareholders will own the remaining portion of the combined company on a fully diluted basis.

Following the closing, the combined company will continue to be led by Decker. Two current members of the board of directors of Evoqua are expected to join Xylem’s board of directors.

Connect

Inside The Story

XylemEvoqua

About Joe Palmisano

Joe Palmisano is editorial director of Connect Money, where he oversees daily coverage of alternative assets, direct investments, financial advisory and the economy. He brings three decades of experience as a financial journalist, analyst and portfolio manager. Before joining Connect Money, Palmisano wrote for The Wall Street Journal, covering foreign exchange, global fixed-income and equity markets. He later served as a senior research analyst and portfolio manager, producing market analysis and managing foreign exchange and U.S. equity portfolios for FX Concepts. His work has also appeared in SFO Magazine and CMT Association publications. Palmisano earned a bachelor’s degree in finance from The American University and holds the Chartered Market Technician (CMT) designation and is a member of the CFA Institute.